Breakout Ultra Tight – Top 5 Signals for Jun 23, 2026
5 signals. Healthcare leads (2). price range $29-$279. 3 with insider selling.
What This Signal Is
High momentum stock screener for swing trading opportunities. Identifies stocks with strong momentum characteristics suitable for swing trading (1-4 week holds). Includes multiple variants: breakout, pullback, aggressive momentum, and volatile high-beta.
Entry Criteria:
- Strong RSI momentum (configurable thresholds)
- Volume surge above average
- Price momentum confirmation
- Minimum ADV: $25M+ (varies by variant)
- Earnings buffer: 7 days pre/post earnings
- Variant-specific filters applied
Holding period: 1-4 weeks | Risk level: Medium-High
Market Context
The sharp divergence between major indices on June 23rd tells an important story: tech-heavy growth names are bearing the brunt of today's selling pressure, with the Nasdaq shedding over 2%, while the Dow's near-flat performance suggests investors are rotating toward more defensive, value-oriented positioning. This kind of bifurcation creates a challenging environment for momentum-swing strategies, which typically rely on clean, directional price action. When market leadership is fragmenting across sectors, signals can be noisier and follow-through less reliable.
The VIX jumping over 12% to sit near 19.4 is the most critical factor for momentum-swing traders today. While 19 isn't historically extreme, a single-day spike of this magnitude signals a meaningful uptick in fear and uncertainty, which tends to widen intraday price ranges and increase the likelihood of false breakouts. On one hand, elevated volatility can amplify gains when a swing trade moves in your favor; on the other, stop-loss levels need to be calibrated more carefully to avoid getting shaken out by erratic intraday swings before a move develops.
Healthcare emerging as the top sector for today's signals fits the current risk-off tone well. Defensive sectors like healthcare historically attract capital during broad market pullbacks, as investors seek stability and earnings resilience when appetite for high-growth risk diminishes. This sector rotation dynamic lends some fundamental support to momentum signals in this space, though traders should remain mindful that even defensive sectors can experience short-term volatility spillover when the VIX is trending sharply higher on an intraday basis.
📊 Signals (5 of 5 total)
Ranked by composite momentum score (higher = stronger momentum)
| # | Ticker | Company | Sector | Price | Score | Insider | MCap |
|---|---|---|---|---|---|---|---|
| 1 | LGND | Ligand Pharmaceuticals... | Healthcare | $279.44 | 1.00 | -$2,745,061 | $5.6B |
| 2 | KLIC | Kulicke and Soffa Indu... | Technology | $127.10 | 0.40 | -$11,162,803 | $6.7B |
| 3 | ACA | Arcosa, Inc. | Industrials | $144.92 | 0.32 | — | $7.1B |
| 4 | FHB | First Hawaiian, Inc. | Financial Services | $28.60 | 0.25 | — | $3.5B |
| 5 | CNTA | Centessa Pharmaceutica... | Healthcare | $40.50 | 0.00 | -$836,142 | $6.3B |
Field Notes
Sector concentration: Healthcare (2), Technology (1), Industrials (1)
Insider selling: KLIC (Kulicke and Soffa Industries, Inc., -$11,162,803), LGND (Ligand Pharmaceuticals Incorporated, -$2,745,061), CNTA (Centessa Pharmaceuticals plc, -$836,142)
Data coverage: 60.0% insider, 0.0% congressional, 0.0% earnings, 20.0% news
Peer Analysis
CNTA (Centessa Pharmaceuticals plc): Leads 5 peers: APGE ($132.88), XENE ($54.61), AAPG ($17.01), RARE ($28.76), CELC ($90.21)
LGND (Ligand Pharmaceuticals Incorporated): Leads 5 peers: PRAX ($305.37), BLTE ($145.09), MIRM ($111.07), ACAD ($22.60), ADMA ($8.69)
ACA (Arcosa, Inc.): Leads 5 peers: BZ ($13.14), NPO ($367.37), MSM ($116.26), ALK ($49.21), TREX ($45.34)
FHB (First Hawaiian, Inc.): Leads 5 peers: BKU ($49.12), CATY ($60.89), WSFS ($76.00), FBP ($26.23), CBU ($64.58)
KLIC (Kulicke and Soffa Industries, Inc.): Leads 5 peers: AAOI ($147.44), DQ ($13.47), VECO ($74.84), POWI ($80.57), VSH ($58.96)
Recent Headlines
ACA (Arcosa, Inc.)
- Is CRH's $8.5 Billion Arcosa Acquisition a Game Changer?
- Arcosa Inc (ACA) Stock Up 6.7% but GF Value Says Overvalued -- GF Score: 78/100
- $HAREHOLDER ALERT: The M&A Class Action Firm Announces An Investigation of Arcosa, Inc. (NYSE: ACA)
- CRH to Acquire Arcosa for $8.5 Billion Amid Market Skepticism
- Shareholder Alert: Ademi LLP investigates whether Arcosa, Inc. is obtaining a Fair Price for Public Shareholders
- Shareholder Alert: Ademi LLP investigates whether Arcosa, Inc. is obtaining a Fair Price for Public Shareholders
- ACA Stock Alert: Halper Sadeh LLC is Investigating Whether Arcosa, Inc. is Obtaining a Fair Price for its Shareholders
- ACA Stock Alert: Halper Sadeh LLC is Investigating Whether Arcosa, Inc. is Obtaining a Fair Price for its Shareholders
- Stock Futures Cautiously Higher Amid Middle East Uncertainty
- Arcosa Stock Rises on $8.5 Billion Acquisition by CRH
Vlad's Take
Today's signals: 3 signals showing insider selling warrant caution.
Independent, data-driven signals.
No hype. No promotions. Just experimental market research from EverHint.
👉 This is not financial advice. Market conditions change rapidly.
Do your own due diligence.
See https://www.everhint.com/disclaimer/ and https://www.everhint.com/faqs/
📢 Support the project by liking, sharing, or subscribing — it helps more readers discover these signals.